Discovery and clinical implications of urotensin II
Naruse, M.; Nagata, D.; Tanabe, A.; Imaki, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl. 9: 685-693
2004
ISSN/ISBN: 0047-1852 PMID: 15506473 Document Number: 569061
Document emailed within 1 workday
Related Documents
Takahashi, K.; Totsune, K.; Murakami, O. 2004: Urotensin receptors and urotensin-mediated signal transduction Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 698-701Kaur, N.; Sharma, A.K.; Shakeel, A.; Kumar, V.; Singh, A.; Gupta, A.; Suhag, D.; Rajput, S.K.; Mukherjee, M. 2017: Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery Current Topics in Medicinal Chemistry 17(22): 2495-2508
Muñoz García, D. 1983: A Copernican revolution in neuropathology. Implications of the discovery of lesions in the nucleus basalis in Alzheimer's disease Archivos de Neurobiologia 46(3): 159-160
Dittrich, H.M.; Hahn von Dorsche, H. 1978: The anatomical and histological investigation of the pancreas in the 19th century and till the discovery of insulin (1921). 2. The pancreas research from the discovery of islets (1869) till the discovery of pancreas-diabetes (1889) Anatomischer Anzeiger 143(3): 231-241
Zhang, L.-F.; Ding, W.-H.; Ke, Y.-N. 2007: Urotensin Ii and atherosclerosis Zhonghua Xin Xue Guan Bing Za Zhi 35(5): 491-493
Totsune, K.; Takahashi, K.; Murakami, O. 2004: Measurement of urotensin Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 705-708
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Watanabe, T. 2008: Urotensin Ii promotes atherosclerosis SEIKAGAKU. Journal of Japanese Biochemical Society 80(1): 40-44
Piech, J.; Skoczylas, A. 2008: The role of urotensin Ii in human pathophysiology Wiadomosci Lekarskie 61(10-12): 277-282
Del Moral F; Palacios; Rebollo; Espejo 1999: Discovery and clinical development of Sildenafil Actas Espanolas de Psiquiatria 27(Supl 1): 46-53
Gibson, A.; Conyers, S.; Bern, H.A. 1988: The influence of urotensin II on calcium flux in rat aorta Journal of Pharmacy and Pharmacology 40(12): 893-895
Copp, D.H. 1994: Calcitonin: discovery, development, and clinical application Clinical and Investigative Medicine. Medecine Clinique et Experimentale 17(3): 268-277
Jung, L.; Holle, L.; Dalton, W.S. 2004: Discovery, Development, and clinical applications of bortezomib Oncology 18(14 Suppl. 11): 4-13
Yoshimoto, T.; Hirata, Y. 2004: Autocrine/paracrine role of urotensin Ii as a growth factor Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 711-714
Itoh, H.; Itoh, Y.; Rivier, J.; Lederis, K. 1987: Contraction of major artery segments of rat by fish neuropeptide urotensin II American Journal of Physiology 252(2 Pt 2): R361-R366
Neumann, F.; Graef K J. 1975: Discovery development mode of action and clinical use of cyproterone acetate Journal of International Medical Research 3(Suppl 4): 1-9
Favre, R.; Kleisbauer, J.P.; Poirier, R.; Laval, P.; Serafino, X. 1972: Distribution in the course of the year of the clinical discovery of primary bronchial carcinomas Marseille Medical 109(4): 301-304
Wong, T.Yin. 2014: How to bridge the "valley of death" between a research discovery and clinical application? Annals of the Academy of Medicine Singapore 43(8): 422-424
Feng, F.P.; Zhang, W.; Zhou, G. 1994: Discovery and clinical investigation of Lyme disease in Beijing area Zhonghua Liu Xing Bing Xue Za Zhi 15(1): 10-13